Nitroglycerin SL Tablets (VA-27-00011802)
Department of Veterans Affairs
Why this score
Active buyer ($35.4B FY24–FY26), posted today; but full and open (strong incumbent).
Solicitation # 75N98027Q00017Updated Oct 20, 2026
This RFP closed on Nov 4, 2026.
Nov 4, 2026
Responses were due Nov 4, 2026, 1:00 PM EST
Same NAICS group or Healthcare & Medical, nearby first, ranked by score.
Department of Veterans Affairs
Why this score
Active buyer ($35.4B FY24–FY26), posted today; but full and open (strong incumbent).
Indian Health Service · Crownpoint, NM
Why this score
New this week, typical award ~$1.5M; but only 4 days left.
National Institutes of Health · Bethesda, MD
Why this score
New this week, 11 days to respond; but small typical award (~$69K).
Defense Health Agency (DHA) · JBSA Ft Sam Houston, TX
Why this score
SDVOSB set-aside, 13 days to respond; but small typical award (~$74K).
Department of Veterans Affairs · Baltimore
Why this score
New this week, active buyer ($297M FY24–FY26); but small typical award (~$121K).
Why this score
Active buyer ($35.4B FY24–FY26), 43 days to respond; but full and open (strong incumbent).
RFP Detector Scores are informational.How we score →
Summary by RFP Detector
National Institutes of Health (National Institutes of Health Olao), part of the Department of Health and Human Services, posted a combined synopsis/solicitation titled “NOI - B2B Award entitled - Developing Red Cell-Sp” under solicitation number 75N98027Q00017. It was posted on Oct 20, 2026. The response deadline was Nov 4, 2026, 1:00 PM EST. It is classified under NAICS 325411 (Medicinal and Botanical Manufacturing) and product/service code 6505. No set-aside is listed. The listed point of contact is CAPOBIANCO, NICHOLAS S.
Score at publication
Every RFP starts at 50. Each factor adds or subtracts points compared with a typical RFP; unknown data counts as neutral.
Frozen at publication: closed RFPs are not re-scored.
Starts at 50
No value published, and there isn't enough award history to estimate one. Scored as neutral.
Notice signals a sole-source or brand-name intent.
75 other RFPs from National Institutes of Health on RFP Detector in the past 12 months; no award history found.
Solicitation, bids due: 15 days to respond (due Nov 4, 2026, 1:00 PM EST).
Documents not listed, named contact with email and phone, 390-word description.
Posted today.
Capped at 30: not openly competed
Informational, not advice to bid or not bid. Score version 1.0.0, evaluated Oct 20, 2026.
Eligibility · Full and open competition
Full and open competition means the notice states no set-aside: any responsible business can respond, subject to the requirements in the notice.
Not stated in a form we could extract. See the official solicitation for requirements, evaluation criteria and submission steps.
From the official notice
(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith the format in FAR Subpart 12.6, as supplemented with additional information includedin this notice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00017. This solicitation is issued as a Notice ofIntent (NOI) for a non-competitive combined synopsis/solicitation to award a contract orpurchase order without providing for full and open competition (including brand-name, ifapplicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a purchase order on a non-competitive basis to Purdue University, Purdue Institute for Drug Discovery (DRUG), 575 Stadium Mall Drive, West Lafayette, IN 47907, for the synthesis, scale-up, and characterization of lead Spleen Tyrosine Kinase (SYK) inhibitors in support of the NIH Bench-to-Bedside study "Developing Red Cell-Specific Spleen Tyrosine Kinase (SYK) Inhibitors for Treating Sickle Cell Disease." Rationale for non-competitive award: The proposed acquisition is a continuation of project-specific medicinal chemistry work under the NIH Bench-to-Bedside study "Developing Red Cell-Specific Spleen Tyrosine Kinase (SYK) Inhibitors for Treating Sickle Cell Disease." Dr. Philip S. Low's laboratory at Purdue University is the identified extramural medicinal chemistry collaborator for this project and has performed the prior design and synthesis work associated with the SYK inhibitor candidates being advanced under the study. The Year 1 requirement is specifically for the synthesis, scale-up, and characterization of lead SYK inhibitors S1115 and S1213 for subsequent biological evaluation by NIH investigators. Purdue possesses the project-specific knowledge and experience associated with these compounds. Use of another source would require duplication of prior research before the source could continue the current effort, resulting in delay and technical risk. Based on these circumstances, Purdue University is the only source reasonably available to perform this specific Year 1 requirement. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv) The associated NAICS code is 325411, Medicinal and Botanical Manufacturing, and the small business size standard is 1,250 employees. This requirement is not set aside for small business.
No documents are listed for this notice.
CAPOBIANCO, NICHOLAS S
PrimaryPoints of contact as published on the notice.
Combined Synopsis/Solicitation posted
Responses were due
74 open RFPs from this issuer and its offices.
National Institutes of Health · Bethesda, MD
Why this score
Full and open, active buyer ($113M FY24–FY26); but only 1 day left.
National Institutes of Health
Why this score
Active buyer ($218M FY24–FY26); but only 1 day left.
National Institutes of Health · Bethesda, MD
Why this score
New this week; but only 1 day left.
National Institutes of Health
Why this score
Active buyer ($4.4B FY24–FY26), typical award ~$901K; but only 1 day left.
National Institutes of Health
Why this score
Active buyer ($4.4B FY24–FY26), typical award ~$901K; but only 1 day left.
National Institutes of Health
Why this score
Full and open, active buyer ($113M FY24–FY26); but only 1 day left.
RFP Detector Scores are informational.How we score →
Official federal notice. Updated Oct 20, 2026.
Official solicitation:Sign in free to open the official solicitation
RFP Detector is an independent service and is not affiliated with any government agency. Scores are informational.
RFP Detector is not affiliated with the organization that issued this RFP. Always rely on the official notice and confirm every date and requirement with the issuer.